Des-γ-carboxy Prothrombin (DCP), also known as Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), is a unique and clinically significant biomarker often included in blood panels, particularly in the context of liver health and hepatocellular carcinoma (HCC) screening. DCP is an abnormal form of prothrombin, a vital protein for blood coagulation, produced in the liver. It arises when there is a deficiency of vitamin K or a dysfunction in the carboxylation system within the liver cells. In healthy individuals, prothrombin is fully carboxylated in the presence of vitamin K, allowing it to play its crucial role in the coagulation cascade. However, in certain pathological conditions, particularly in the presence of hepatic malignancies such as HCC, the capacity for complete carboxylation is impaired, leading to the release of partially carboxylated or completely uncarboxylated prothrombin, identified as DCP.
The clinical importance of DCP lies in its utility as a tumor marker for the early detection and monitoring of HCC. Studies have shown that DCP levels are significantly elevated in many patients with HCC, often correlating with tumor size, stage, and prognosis. This makes DCP a valuable tool in the diagnostic process, particularly in conjunction with other tumor markers like alpha-fetoprotein (AFP) and imaging studies. DCP's sensitivity and specificity vary based on the cutoff values used and the population being studied, but it is generally regarded as a more specific marker for HCC than AFP, especially in patients with cirrhosis, where AFP levels may be elevated without the presence of HCC.
Additionally, DCP measurements can be useful in monitoring the treatment response and recurrence in patients undergoing therapy for HCC. An increasing trend in DCP levels may indicate tumor progression or recurrence, while a decrease might suggest a favorable response to treatment.
However, it's important to note that elevated DCP levels are not exclusively associated with HCC. They can also be observed in other liver diseases, such as chronic hepatitis and cirrhosis, or in conditions that affect vitamin K metabolism. Therefore, DCP should be interpreted in the context of a comprehensive clinical evaluation and in conjunction with other diagnostic modalities.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.